Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
drugs
5
×
fda
5
×
life sciences
national blog main
boston blog main
boston top stories
clinical trials
boston
national top stories
new york blog main
new york top stories
alnylam pharmaceuticals
onpattro
patisiran
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
acute hepatic porphyrias
akcea therapeutics
akin akinc
allopregnanolone
aminolevulinic acid
blueprint medicines
boulder/denver blog main
boulder/denver top stories
brexanolone
cancer
cannabidiol
companion diagnostic
detroit blog main
detroit top stories
dna sequencing
dravet syndrome
entrectinib
epidiolex
european medicines agency
express scripts
fen-phen
fenfluramine
What
drug
5
×
fda
medicine
5
×
approved
ago
alnylam
interference
new
oks
pharmaceuticals
rna
rnai
second
weeks
approval
approves
battle
brexanolone
cancer
cannabis
cells
data
deeper
depression
derivative
devastating
disorder
dna
ema
employ
epilepsy
europe
fast
fingerprint
follows
form
gene
genetic
going
gw
Language
Current search:
fda
×
drug
×
drugs
×
medicine
×
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug